Literature DB >> 16379514

Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder.

Nick C Patel1, Melissa P DelBello, Paul E Keck, Stephen M Strakowski.   

Abstract

PURPOSE: The aim of this study was to compare the longitudinal use of psychotropic medications in African-American and Caucasian adolescents with a diagnosis of bipolar disorder following their first psychiatric hospitalization.
METHODS: Age- and gender-matched African-American (n=16) and Caucasian (n=16) adolescents, between the ages of 12 and 18 years and meeting Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria for bipolar I disorder, manic or mixed, were evaluated over a period of 1 year following their first psychiatric hospitalization for a mood episode. Medication prescription and adherence during follow-up were compared between ethnic groups.
RESULTS: African-American adolescents received antipsychotic prescription for a significantly greater percentage of time during follow-up than Caucasian adolescents, after adjusting for rate of psychotic features (79% versus 40%; p=0.05). African-American and Caucasian patients received mood stabilizer/anticonvulsant prescription for similar percentages of time during follow-up. African-American and Caucasian adolescents exhibited similar rates of full adherence to antipsychotics, mood stabilizers/anticonvulsants, and all psychotropic medications.
CONCLUSIONS: African-American adolescents were prescribed atypical antipsychotic medications for longer periods of time than Caucasian adolescents, but reasons for this finding were unclear. Additional research efforts in adolescent bipolar disorder are needed to explore factors associated with ethnic disparity in pharmacological treatment interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16379514     DOI: 10.1089/cap.2005.15.938

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  8 in total

1.  Adolescents' commitment to continuing psychotropic medication: a preliminary investigation of considerations, contradictions, and correlates.

Authors:  Tally Moses
Journal:  Child Psychiatry Hum Dev       Date:  2011-02

2.  Medication Adherence Among Adolescents with Bipolar Disorder.

Authors:  Tina R Goldstein; Megan Krantz; John Merranko; Matthew Garcia; Loren Sobel; Carlos Rodriguez; Antoine Douaihy; David Axelson; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-07-15       Impact factor: 2.576

3.  Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.

Authors:  Sarah L Logan; Laura Carpenter; R Scott Leslie; Kelly S Hunt; Elizabeth Garrett-Mayer; Jane Charles; Joyce S Nicholas
Journal:  J Autism Dev Disord       Date:  2014-11

4.  Phenomenology, socio-demographic factors and outcome upon discharge of manic and mixed episodes in hospitalized adolescents: a chart review.

Authors:  Julie Brunelle; Angèle Consoli; Marie-Laure Tanguy; Christophe Huynh; Didier Perisse; Emmanuelle Deniau; Jean-Marc Guilé; Priscille Gérardin; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-01-06       Impact factor: 4.785

5.  Treatment alliance and adherence in bipolar disorder.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2018-11-09

6.  A brief motivational intervention for enhancing medication adherence for adolescents with bipolar disorder: A pilot randomized trial.

Authors:  Tina R Goldstein; Megan L Krantz; Rachael K Fersch-Podrat; Nina J Hotkowski; John Merranko; Loren Sobel; David Axelson; Boris Birmaher; Antoine Douaihy
Journal:  J Affect Disord       Date:  2020-01-07       Impact factor: 4.839

7.  Evidence review and clinical guidance for the use of ziprasidone in Canada.

Authors:  David M Gardner; Andrea L Murphy; Stan Kutcher; Serge Beaulieu; Carlo Carandang; Alain Labelle; Pierre Lalonde; Ashok Malla; Heather Milliken; Claire O'Donovan; Ayal Schaffer; Jorge Soni; Valerie H Taylor; Richard Williams
Journal:  Ann Gen Psychiatry       Date:  2013-01-24       Impact factor: 3.455

8.  Effective therapeutic dosage of antipsychotic medications in patients with psychotic symptoms: Is there a racial difference?

Authors:  Muideen O Bakare
Journal:  BMC Res Notes       Date:  2008-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.